Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rocco Sclafani"'
Autor:
Clara Riccini, Sara Cavallini, Andrea Santucci, Claudio Cavallini, Stefano Savonitto, Paolo Verdecchia, Rocco Sclafani, Stefano De Servi, Stefano Coiro, Fabio Angeli
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 60:118-126
Objectives CD40 ligand (CD40L), a transmembrane glycoprotein belonging to the tumor necrosis factor family and expressed by a variety of cells, is involved in the basic mechanisms of inflammation, atherosclerosis and thrombosis. Some studies suggest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ae880ce889c1ea5c6a71fc8ac80b6a2
https://doi.org/10.1515/cclm-2021-0817
https://doi.org/10.1515/cclm-2021-0817
Autor:
Carlo Briguori, Franco Fabbiocchi, Matteo Sturla, Rocco Sclafani, Giulio G. Stefanini, Mauro Chiarito, A. Paggi, Fabrizio Tomai, Corrado Tamburino, Daniela Trabattoni, Gaetano Gioffrè, Arturo Giordano, Massimo Mancone, Gennaro Sardella
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 23(2)
AIMS Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease and have a worse prognosis after percutaneous coronary interventions (PCI). The BioFreedom polymer-free biolimus-A9-eluting stent (PF-BES) has shown promi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c65b979d9f9167475c97658a4bb2e1e4
https://pubmed.ncbi.nlm.nih.gov/34632982
https://pubmed.ncbi.nlm.nih.gov/34632982
Autor:
Rocco Sclafani, Roberto Annunziata, Salvatore Notaristefano, Claudio Cavallini, Francesco Notaristefano, Matteo Rocco Reccia, Giuseppe Ambrosio
Publikováno v:
Cardiovascular Revascularization Medicine. 19:536-539
Trancatheter heart valve (THV) thrombosis is effectively treated with anticoagulation but alternative therapies are required when a faster gradient reduction is needed. Open heart surgery has been rarely performed due to the high perioperative mortal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44bc2e04d2aea006a92be218190314ad
https://doi.org/10.1016/j.carrev.2017.12.005
https://doi.org/10.1016/j.carrev.2017.12.005
Autor:
Alaide Chieffo, Marco B. Ancona, Francesco Burzotta, Vittorio Pazzanese, Carlo Briguori, Carlo Trani, Tommaso Piva, Federico De Marco, Maurizio Di Biasi, Paolo Pagnotta, Gavino Casu, Gennaro Giustino, Matteo Montorfano, Federico Pappalardo, Giuseppe Tarantini, Roberto Garbo, Gerlando Preti, Elisa Nicolini, Rocco Sclafani, Giuseppe Colonna, Marco Mojoli, Massimo Siviglia, Cristiana Denurra, Francesco Caprioglio
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 15(15)
AIMS The aim of this study was to investigate nationwide trends and clinical outcomes of the Impella device for cardiogenic shock (CS) and high-risk percutaneous coronary intervention (HR-PCI). METHODS AND RESULTS The IMP-IT study was a multicentre o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a76ba47766bde49c70b583d45e6bd6e4
https://pubmed.ncbi.nlm.nih.gov/31422925
https://pubmed.ncbi.nlm.nih.gov/31422925
Autor:
Nicola Corcione, Giulio G. Stefanini, Alessandro Sciahbasi, Palma Luisa Nestola, Nicola Signore, Massimo Mancone, Corrado Tamburino, Fabrizio Tomai, Francesco Scardaci, Andrea Rolandi, Martino Pepe, Francesco Rotolo, Mario Lombardi, Arturo Giordano, Alberto Morello, Franco Fabbiocchi, Gaetano Gioffrè, Gennaro Sardella, Rocco Sclafani, A. Paggi, Carlo Briguori
Patients with diabetes mellitus (DM) have worse outcomes after percutaneous coronary intervention (PCI). Recent evidences suggest a differential impact of insulin-treated and noninsulin-treated DM on prognosis. We evaluated the clinical outcome of di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d2f54c3a13ac18aebbf5c074687d9b
http://hdl.handle.net/11573/1453665
http://hdl.handle.net/11573/1453665
Autor:
Francesco, Notaristefano, Matteo Rocco, Reccia, Salvatore, Notaristefano, Roberto, Annunziata, Rocco, Sclafani, Giuseppe, Ambrosio, Claudio, Cavallini
Trancatheter heart valve (THV) thrombosis is effectively treated with anticoagulation but alternative therapies are required when a faster gradient reduction is needed. Open heart surgery has been rarely performed due to the high perioperative mortal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::bb1824de5145a702b4410aee6e867fa3
http://hdl.handle.net/11391/1425643
http://hdl.handle.net/11391/1425643
Autor:
Corrado Tamburino, Franco Fabbiocchi, Nicola Signore, A. Paggi, Massimo Mancone, Francesco Scardaci, Francesco Rotolo, Rocco Sclafani, Mario Lombardi, Gennaro Sardella, Simone Calcagno, Fabrizio Tomai, Arturo Giordano, Alessandro Sciahbasi, Mauro Chiarito, Andrea Rolandi, Gaetano Gioffrè, Giulio G. Stefanini, Carlo Briguori
Aims Polymer-free biolimus-eluting stents (PF-BES) have been shown to be superior to bare metal stents in high bleeding risk (HBR) patients treated with one-month dual antiplatelet therapy (DAPT). However, limited evidence is available on PF-BES in n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69551c7e3bc150d6223659a155098e70
http://hdl.handle.net/11573/1152225
http://hdl.handle.net/11573/1152225
Autor:
Giuseppe, Ciliberti, Francesco, Notaristefano, Rocco, Sclafani, Salvatore, Notaristefano, Claudio, Giombolini, Federico, Fortunati, Giuseppe, Ambrosio, Claudio, Cavallini
Publikováno v:
Giornale italiano di cardiologia (2006). 16(6)
Spontaneous coronary artery dissection (SCAD) is a non-atherosclerotic coronary artery disease, which typically affects women with a low cardiovascular risk profile, and its prevalence as a cause of acute coronary syndrome and sudden death is probabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f573cd9e526f4148326201feb87cbddc
https://pubmed.ncbi.nlm.nih.gov/26156699
https://pubmed.ncbi.nlm.nih.gov/26156699